These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 37232081)
21. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children. Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324 [TBL] [Abstract][Full Text] [Related]
22. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials. Yang M; He Q; Gao F; Nirantharakumar K; Veenith T; Qin X; Page AT; Wong MCS; Huang J; Kuo ZC; Xia B; Zhang C; He Y; Meng W; Yuan J; Pan Y BMC Med; 2021 Dec; 19(1):316. PubMed ID: 34856983 [TBL] [Abstract][Full Text] [Related]
23. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Liu Z; Alsaggaf R; McGlynn KA; Anderson LA; Tsai HT; Zhu B; Zhu Y; Mbulaiteye SM; Gadalla SM; Koshiol J Gut; 2019 Aug; 68(8):1458-1464. PubMed ID: 30448774 [TBL] [Abstract][Full Text] [Related]
24. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany. Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361 [TBL] [Abstract][Full Text] [Related]
25. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans. Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480 [TBL] [Abstract][Full Text] [Related]
26. Associations between pre-diagnostic plasma metabolites and biliary tract cancer risk in the prospective UK Biobank cohort. Gunchick V; Jia G; Wen W; Long J; Shu XO; Zheng W Am J Epidemiol; 2024 Oct; ():. PubMed ID: 39415432 [TBL] [Abstract][Full Text] [Related]
27. Association between green tea/coffee consumption and biliary tract cancer: A population-based cohort study in Japan. Makiuchi T; Sobue T; Kitamura T; Ishihara J; Sawada N; Iwasaki M; Sasazuki S; Yamaji T; Shimazu T; Tsugane S Cancer Sci; 2016 Jan; 107(1):76-83. PubMed ID: 26530716 [TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study. Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677 [TBL] [Abstract][Full Text] [Related]
29. Regular proton pump inhibitor use and incident dementia: population-based cohort study. Zhang P; Li Z; Chen P; Zhang A; Zeng Y; Zhang X; Huang Q; Liu D; Qi S; Mao C BMC Med; 2022 Sep; 20(1):271. PubMed ID: 36045363 [TBL] [Abstract][Full Text] [Related]
30. Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank. Zhang XY; He QS; Jing Z; He JX; Yuan JQ; Dai XY Front Pharmacol; 2022; 13():949699. PubMed ID: 36438798 [No Abstract] [Full Text] [Related]
31. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline. Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266 [TBL] [Abstract][Full Text] [Related]
32. Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium. Oze I; Ito H; Koyanagi YN; Abe SK; Rahman MS; Islam MR; Saito E; Gupta PC; Sawada N; Tamakoshi A; Shu XO; Sakata R; Malekzadeh R; Tsuji I; Kim J; Nagata C; You SL; Park SK; Yuan JM; Shin MH; Kweon SS; Pednekar MS; Tsugane S; Kimura T; Gao YT; Cai H; Pourshams A; Lu Y; Kanemura S; Wada K; Sugawara Y; Chen CJ; Chen Y; Shin A; Wang R; Ahn YO; Shin MH; Ahsan H; Boffetta P; Chia KS; Qiao YL; Rothman N; Zheng W; Inoue M; Kang D; Matsuo K Int J Cancer; 2024 Apr; 154(7):1174-1190. PubMed ID: 37966009 [TBL] [Abstract][Full Text] [Related]
33. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015. Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474 [TBL] [Abstract][Full Text] [Related]
34. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109 [TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor use represents an independent risk factor for myocardial infarction. Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395 [TBL] [Abstract][Full Text] [Related]
36. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication. Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313 [TBL] [Abstract][Full Text] [Related]
37. Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population-based and multicenter cohort study using a common data model. Park DH; Seo SI; Lee KJ; Kim J; Kim Y; Seo WW; Lee HS; Shin WG; Yoo JJ J Gastroenterol Hepatol; 2022 Aug; 37(8):1534-1543. PubMed ID: 35501296 [TBL] [Abstract][Full Text] [Related]
38. Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study. Larsson SC; Giovannucci EL; Wolk A J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27281756 [TBL] [Abstract][Full Text] [Related]
39. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. Khalili H; Huang ES; Jacobson BC; Camargo CA; Feskanich D; Chan AT BMJ; 2012 Jan; 344():e372. PubMed ID: 22294756 [TBL] [Abstract][Full Text] [Related]
40. Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital-based case-control study and a population-based cohort study. Yee J; Han HW; Gwak HS Br J Clin Pharmacol; 2022 Jun; 88(6):2738-2746. PubMed ID: 34970788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]